台股 » 個股 » 生展 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生展

(8279)
  • 股價
    132.0
  • 漲跌
    ▼1.0
  • 漲幅
    -0.75%
  • 成交量
    106
  • 產業
    上櫃 生技醫療類股
  • 67人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
生展 (8279)籌碼相關-康和-延平 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

康和-延平 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/06/2000.000160.00161.00010-0.19%
2024/01/1100.000153.00151.00010-0.20%
2023/10/0600.000.2165.00169.50-0.210-2.24%
2023/09/210.2169.0000.00167.000.2131.41%
2023/09/200.1169.0000.00169.000.1130.38%
2023/08/1000.000.1171.99171.50-0.127-0.19%
2023/08/0900.000.1170.48171.50-0.127-0.29%
2023/04/250.1188.0000.00177.000.1510.10%
2023/03/080.1173.0000.00170.500.1640.08%
2023/03/0700.000.1179.00177.50-0.160-0.08%
2023/03/0100.000.1169.00168.50-0.157-0.09%
2023/02/2300.000.1168.00166.00-0.158-0.09%
2022/12/270.1161.5300.00163.000.1710.14%
2022/12/2000.000.1159.00154.50-0.162-0.08%
2022/12/0900.000.1160.00160.00-0.159-0.08%
2022/12/070.1151.000.1157.50153.000590.00%
2022/11/1700.000.1149.50149.50-0.174-0.08%
2022/09/290142.0000.00143.5001030.01%
2022/09/190157.5000.00157.0001020.02%
2022/08/250.1165.8000.00168.000.1850.06%
2022/07/290.1134.0000.00134.500.1490.10%
2022/07/0600.000118.00118.00048-0.06%
2022/06/1600.000128.50126.50045-0.09%
2022/06/150.1127.5000.00128.500.1440.11%
2022/06/100.1135.0000.00133.000.1410.12%
2022/04/2700.000.1130.00131.00-0.167-0.07%
2022/04/1200.000.1127.00127.00-0.167-0.15%
2022/03/1700.000.1128.00127.00-0.172-0.07%
2022/03/1600.000.1126.00125.00-0.172-0.07%
2022/03/010.1120.5000.00122.000.1710.07%
2022/02/250.1121.0000.00121.500.1710.07%
2022/01/2600.000.1130.00128.00-0.158-0.14%
2022/01/2000.000.1125.00128.00-0.145-0.22%
2021/12/0200.000.1109.00109.00-0.120-0.48%
2020/06/090.1116.0000.00116.500.1710.14%
2019/12/1000.000.1116.50116.50-0.169-0.14%
2019/10/2800.001124.50125.50-176-1.30%
2019/08/140.1137.0000.00137.000.11040.10%
2019/07/2400.001.1150.91150.50-1.184-1.30%
2019/07/160.1153.5000.00154.500.1720.14%
2019/07/100.1147.001148.00147.00-0.962-1.45%
2019/03/0600.001113.00113.50-132-3.06%
2018/08/171103.0000.00103.001801.25%
2018/04/241167.0000.00161.5013740.27%
2018/02/011183.0000.00182.5013230.31%
2018/01/301180.0000.00177.0013240.31%
2018/01/2900.002183.00183.00-2325-0.61%
2018/01/2600.001178.50179.50-1321-0.31%
2018/01/251175.001177.50175.5003170.00%
2018/01/222171.2500.00172.5023130.64%
2018/01/1900.001179.00174.00-1310-0.32%
2018/01/181168.0000.00171.5013000.33%
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
〈聯合再生展望〉洪傳獻:TOPCon技術明年成主流 獲利表現佳Anue鉅亨-2023/10/16
生展 相關文章